141 related articles for article (PubMed ID: 2541748)
1. Patterns of antibody recognition of selected conserved amino acid sequences from the HIV envelope in sera from different stages of HIV infection.
Shafferman A; Lennox J; Grosfeld H; Sadoff J; Redfield RR; Burke DS
AIDS Res Hum Retroviruses; 1989 Feb; 5(1):33-9. PubMed ID: 2541748
[TBL] [Abstract][Full Text] [Related]
2. Antibody recognition of SIVmac envelope peptides in plasma from macaques experimentally infected with SIV/Mne.
Shafferman A; Layne A; Sadoff J; Burke DS; Morton WR; Benveniste RE
AIDS Res Hum Retroviruses; 1989 Jun; 5(3):327-36. PubMed ID: 2543433
[TBL] [Abstract][Full Text] [Related]
3. Antibody-dependent cellular cytotoxicity is directed against both the gp120 and gp41 envelope proteins of HIV.
Evans LA; Thomson-Honnebier G; Steimer K; Paoletti E; Perkus ME; Hollander H; Levy JA
AIDS; 1989 May; 3(5):273-6. PubMed ID: 2548535
[TBL] [Abstract][Full Text] [Related]
4. Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects.
Klasse PJ; Pipkorn R; Blomberg J
Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5225-9. PubMed ID: 2455899
[TBL] [Abstract][Full Text] [Related]
5. Antigenic specificity of antibody-dependent cell-mediated cytotoxicity directed against human immunodeficiency virus in antibody-positive sera.
Koup RA; Sullivan JL; Levine PH; Brewster F; Mahr A; Mazzara G; McKenzie S; Panicali D
J Virol; 1989 Feb; 63(2):584-90. PubMed ID: 2536094
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
[TBL] [Abstract][Full Text] [Related]
7. Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression.
Zwart G; van der Hoek L; Valk M; Cornelissen MT; Baan E; Dekker J; Koot M; Kuiken CL; Goudsmit J
Virology; 1994 Jun; 201(2):285-93. PubMed ID: 7514319
[TBL] [Abstract][Full Text] [Related]
8. The antibody response to the HIV-1 specific "out" (vpu) protein: identification of an immunodominant epitope and correlation of antibody detectability to clinical stages.
Schneider T; Hildebrandt P; Rönspeck W; Weigelt W; Pauli G
AIDS Res Hum Retroviruses; 1990 Jul; 6(7):943-50. PubMed ID: 1697179
[TBL] [Abstract][Full Text] [Related]
9. Characterization and epitope mapping of a human monoclonal antibody reactive with the envelope glycoprotein of human immunodeficiency virus.
Banapour B; Rosenthal K; Rabin L; Sharma V; Young L; Fernandez J; Engleman E; McGrath M; Reyes G; Lifson J
J Immunol; 1987 Dec; 139(12):4027-33. PubMed ID: 2447158
[TBL] [Abstract][Full Text] [Related]
10. Use of the recombinant chimera proteins, LacZ-Env and Gag-Env, for immunological studies on HIV-1 infection.
Morimoto M; Saitoh A; Ueba N; Nakata A; Shinagawa H
AIDS Res Hum Retroviruses; 1993 Oct; 9(10):971-8. PubMed ID: 7506555
[TBL] [Abstract][Full Text] [Related]
11. Cellular immune response to viral peptides in patients exposed to HIV.
Ahearne PM; Matthews TJ; Lyerly HK; White GC; Bolognesi DP; Weinhold KJ
AIDS Res Hum Retroviruses; 1988 Aug; 4(4):259-67. PubMed ID: 2462895
[TBL] [Abstract][Full Text] [Related]
12. Immunodominant glycoprotein 41 epitope identified by seroreactivity in HIV type 1-infected individuals.
Calarota S; Jansson M; Levi M; Broliden K; Libonatti O; Wigzell H; Wahren B
AIDS Res Hum Retroviruses; 1996 May; 12(8):705-13. PubMed ID: 8744581
[TBL] [Abstract][Full Text] [Related]
13. IgG subclass responses to a transmembrane protein (gp41) peptide in HIV infection.
Chiodi F; Mathiesen T; Albert J; Parks E; Norrby E; Wahren B
J Immunol; 1989 Jun; 142(11):3809-14. PubMed ID: 2497181
[TBL] [Abstract][Full Text] [Related]
14. Use of synthetic oligopeptides in identification and characterization of immunological functions in the amino acid sequence of the envelope protein of HIV-1.
Modrow S; Höflacher B; Mellert W; Erfle V; Wahren B; Wolf H
J Acquir Immune Defic Syndr (1988); 1989; 2(1):21-7. PubMed ID: 2537398
[TBL] [Abstract][Full Text] [Related]
15. Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection.
Parekh BS; Pau CP; Kennedy MS; Dobbs TL; McDougal JS
AIDS Res Hum Retroviruses; 2001 Jan; 17(2):137-46. PubMed ID: 11177393
[TBL] [Abstract][Full Text] [Related]
16. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
17. Early detection of antibodies against rDNA-produced HIV proteins with a flow cytometric assay.
Scillian JJ; McHugh TM; Busch MP; Tam M; Fulwyler MJ; Chien DY; Vyas GN
Blood; 1989 May; 73(7):2041-8. PubMed ID: 2540862
[TBL] [Abstract][Full Text] [Related]
18. T cell recognition of HIV synthetic peptides in a natural infection.
Schrier RD; Gnann JW; Landes R; Lockshin C; Richman D; McCutchan A; Kennedy C; Oldstone MB; Nelson JA
J Immunol; 1989 Feb; 142(4):1166-76. PubMed ID: 2783706
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro.
Krowka JF; Stites DP; Jain S; Steimer KS; George-Nascimento C; Gyenes A; Barr PJ; Hollander H; Moss AR; Homsy JM
J Clin Invest; 1989 Apr; 83(4):1198-203. PubMed ID: 2703528
[TBL] [Abstract][Full Text] [Related]
20. Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome.
Golding H; Robey FA; Gates FT; Linder W; Beining PR; Hoffman T; Golding B
J Exp Med; 1988 Mar; 167(3):914-23. PubMed ID: 3127528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
